[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TTRAmyloid Avatar @TTRAmyloid Not Odd

Not Odd posts on X about $gral, $rvmd, $qure, $stok the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% technology brands XXXX%

Social topic influence $gral #227, $rvmd 7.32%, $qure #11, $stok #6, $cytk #5, $exas 4.88%, $capr #47, $srpt #32, $rytm 2.44%, $nvs XXXX%

Top accounts mentioned or mentioned by @biohazard3737 @fluoxefuckboy @persimmonti @statnews @bioinvestor24 @avidresearch @crydevilcrypto @polymarket @polymarkettrade @rickygervais @drmakaryfda @betswrites @crisprtx @ericschmidt151 @yaronwerber @samfazeli8 @tlorriman @bigchodu @craigster771 @crydevil_crypto

Top assets mentioned GRAIL, Inc. Common Stock (GRAL) Revolution Medicines, Inc. Common Stock (RVMD) uniQure N.V. (QURE) Cytokinetics Inc. (CYTK) Exact Sciences Corp (EXAS) Sarepta Therapeutics, Inc. (SRPT) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Novartis AG (NVS) Illumina, Inc. (ILMN) American Tower Corp (AMT) psa10 coin (GRAIL) Xenon Pharmaceuticals Inc (XENE) CRISPR Therapeutics AG (CRSP) Intellia Therapeutics, Inc (NTLA)

Top Social Posts

Top posts by engagements in the last XX hours

"Why $rytm only down X% with pdufa extension and $cytk was down 20%"
X Link 2025-11-07T13:49Z 1383 followers, 1296 engagements

"Robert Blum for biotech executive of the year for not selling $cytk to $nvs"
X Link 2025-11-11T15:36Z 1383 followers, 3653 engagements

"$gral is so far ahead of everyone else there is ZERO competition. Number X be able to have tissue of origin and then run a 100k patient trial"
X Link 2025-12-05T18:14Z 1383 followers, XXX engagements

"I think $lb ends up like $amt at some point"
X Link 2025-11-12T00:15Z 1382 followers, XXX engagements

"$exas with crappy cologuard that is pretty useless is worth 15b. $grail Galleri works and in a MUCH bigger tam only XXX b MC XXX EV was negative XXX m EV when I bought it last year lol. You cant get a valuation gap bigger than this"
X Link 2025-11-19T19:31Z 1382 followers, 1017 engagements

"Dont be in $rvmd for a near term buyout. Theyre not gonna sell for at least a few years if ever"
X Link 2025-12-05T18:38Z 1382 followers, XXX engagements

"$xene nav1.7 program is interesting. But stop wasting money on depression and bipolar theyre likely to fail the phase X looks so bad. Stop wasting capital on psych go all out pain now. Cant invest until they fail psych"
X Link 2025-10-14T13:47Z 1383 followers, 1388 engagements

"Based on cnpv given to already approved meds $rvmd should be able to get multiple cnpv for different indications such as expanding daraxonrasib to 1st line pdac"
X Link 2025-11-08T11:50Z 1381 followers, 1145 engagements

"Instead of muscle aches from statin you might die from liver failure. Stick with the rare devastating diseases. The risk benefit is not good for high cholesterol. Going after high cholesterol is just greed. $crsp $ntla"
X Link 2025-11-17T13:53Z 1381 followers, 1243 engagements

"Jefferies please when youre interviewing the most important oncology companies in the world $rvmd Use an analyst who is familiar with the company who can pronounce the name of the drug and who can speak English"
X Link 2025-11-19T13:48Z 1381 followers, 2156 engagements

"Once $capr has positive P3 controlled data then its no longer crapicor. I think approval is a lock. I change my mind when information change. I had to change my mind about $srpt when their trials turned up negative. Now I have to do the same with $capr"
X Link 2025-12-04T16:51Z 1383 followers, 4112 engagements

"FDA reviewers were against approving $srpt therapies including eteplirsen they were pressured to approve. The FDA reviewers now have the backing of management to not approve questionable therapies. I dont think Prasad is inserting himself into every decision like the $qure bulls are saying"
X Link 2025-12-05T17:36Z 1383 followers, 3896 engagements

"@FluoxeFuckboy @Biohazard3737 March XX 2025: $CAPR -XX% as Peter Marks leaves the FDA. March XX 2026: $CAPR hits $XXX as RFK Jr. personally grants full approval for all degenerative diseases because he likes stem cells"
X Link 2025-12-06T14:09Z 1383 followers, XXX engagements

"If $stok is dropping bc of crappy $qure then thats fine by me. Looking for reinvestment opportunities. Keep slamming it"
X Link 2025-11-03T14:41Z 1382 followers, 1115 engagements

"So many retarded analysts ask dumbass questions on earnings calls. Low IQ retards comparing $stok to $qure"
X Link 2025-11-04T23:05Z 1382 followers, 1460 engagements

"$gral is in a investor desert. Tech investor dont touch it because its not AI software or internet biotech funds wont touch it because they focus on therapeutics. Generalist wont touch it because its life science. Only bio fund with $gral position is baker brothers"
X Link 2025-11-20T14:31Z 1382 followers, XXX engagements

"He gave an example of a company that went up 4x from trough valuation trading at 1bil mcap now has a 1-2 billion drug so should be worth 4-8 billion. That company is $stok"
X Link 2025-11-24T13:05Z 1382 followers, 1670 engagements

"Cancer testing requires high trust. Galleri would be the most trusted mced and take most of the market. by the time any competitor test get on the market the moat would be so deep and wide they wont be able to give the test away. $gral"
X Link 2025-12-05T18:18Z 1382 followers, XXX engagements

"Why do bears not like $fulc data"
X Link 2025-12-06T23:46Z 1383 followers, 1468 engagements